In the E-rosette assay, purified IFNalpha2b-(G4S)n-thymosin alpha1 fusion proteins increased the percentage of E-rosette-forming cells.
In plain wordsIn lab tests, fusion proteins of interferon alpha2b and thymosin alpha1 raised the share of E-rosette-forming cells.
- Peptide
- Thymosin alpha-1
- Outcome
- IncreaseE-rosette-forming cell percentage
- Study
n: not reported in source
Pichia pastoris-expressed fusion proteins- Outcome group
- Immune response · Immune and inflammation
Source sentences
can enhance the percentage of E-rosette-forming-cell in E-rosette assay.
2 context sentences(design, population, supporting numbers)
For developing a fusion protein drug, fusion proteins of IFNalpha2b and Talpha1 linked by different lengths of (G4S)n (n = 1-3) were constructed and expressed in Pichia pastoris.
Antiviral and E-rosette assays were used to investigate the bioactivities of these fusion proteins.
In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.